Partners & Integrations
Medical Devices Integrating GASTER control® Technology
GASTER control® technology is currently integrated into medical devices used in clinical and real-world settings.
These implementations illustrate how a non-invasive biomechanical approach can support the perception of satiety and the regulation of eating behaviors within structured care environments.
Real-World Integration
From Technology Platform to Clinical Use
GASTER control® is designed as a platform technology, enabling integration into devices adapted to specific clinical and functional contexts.
Current integrations demonstrate its use in:
- nutritional and bariatric care
- abdominal support and functional assistance
- structured behavioral and clinical follow-up
These real-world applications provide insight into how the technology can be incorporated into existing care pathways.
NiOU Mi — Satiety Support Device
NiOU Mi is a Class I medical device used by dietitians, nutrition physicians, and bariatric teams.
It integrates GASTER control® technology to:
- support the perception of satiety during meals
- support the regulation of food intake
- assist in the regulation of eating behaviors
- support patient engagement in nutritional follow-up
NiOU Mi is:
- fully external
- non-invasive
- designed for integration into structured care pathways
This device illustrates the use of GASTER control® technology within nutritional and behavioral care settings.
Lipoline — Abdominal Support & External Compression
Lipoline is a medical device designed for abdominal support and controlled external compression using a customized implementation of GASTER control® technology.
Lipoline is:
- prescribed by healthcare professionals
- designed for abdominal wall support and functional assistance
- compatible with medical textile standards
- eligible for reimbursement within certain healthcare systems (e.g., LPPR frameworks)
This application demonstrates the adaptability of the technology beyond satiety-related use.
Clinical Integration
Devices integrating GASTER control® technology are used within structured clinical environments, including:
- multidisciplinary obesity care
- nutritional follow-up programs
- bariatric patient pathways
- post-treatment stabilization phases
These integrations highlight the role of the technology as a complementary tool within broader therapeutic strategies.
Regulatory & Market Integration
GASTER control® technology is developed to align with regulatory and healthcare system requirements.
Integration capabilities include:
- Class I medical device compliance (EU MDR)
- support for CE marking processes
- documentation aligned with clinical and reimbursement expectations
- compatibility with national reimbursement frameworks (e.g., LPPR)
- scalability across international markets
This enables deployment within regulated and prescribable medical-device environments.
A Growing Ecosystem
GASTER control® is part of an expanding ecosystem of partners, including:
- healthcare professionals
- medical device manufacturers
- clinical institutions
- research collaborators
These collaborations contribute to:
- real-world evaluation
- clinical integration
- progressive development of new applications
Link With Technology Platform
All partner devices are based on the same underlying principle:
controlled external abdominal compression supporting the perception of satiety signals.
This ensures:
- consistency of the biomechanical approach
- reproducibility across applications
- adaptability to different clinical contexts
Summary
GASTER control® technology is already integrated into medical devices used in real-world clinical settings.
These implementations demonstrate its potential as a non-invasive, complementary approach supporting the perception of satiety and the regulation of eating behaviors within structured care pathways.